(FTD) is a complex neurodegenerative condition that impacts thousands of individuals and families across the country. Unlike Alzheimer’s disease, FTD primarily alters personality, social behavior, and language before affecting memory, creating unique diagnostic hurdles that even experienced clinicians can misinterpret. A feature in The Wall Street Journal profiling New York OB-GYN Dr. Seth L. Stern brought national attention to why timely detection and early diagnosis are vital for people living with FTD.
The Challenges of Diagnosing Frontotemporal Dementia
Diagnosing FTD can be a complex task, often leading to delayed or inaccurate diagnoses. A shortage of behavioral neurologists and other specialists, limited access to diagnostic tests, and the reluctance to address the topic contribute to the challenges faced by both doctors and patients. This WSJ article highlights personal stories, including that of Dr. Seth L. Stern, an OB-GYN in New York who experienced cognitive issues before being diagnosed with FTD. Such narratives and the stories we hear every day from our patients underline the emotional toll and frustration that individuals and their loved ones experience due to the difficulty in obtaining an accurate diagnosis.
The Significance of Early Detection in Frontotemporal Dementia
Early detection and diagnosis of FTD can be life-changing for individuals and their families. It provides an opportunity to make informed decisions, including financial and legal planning, while individuals are still capable. While anti-amyloid treatments like Leqembi and Kisunla (donanemab) are designed specifically for Alzheimer’s rather than FTD, rapid advancements in cognitive biomarkers and targeted clinical trials are paving the way for specialized FTD therapies. In the meantime, structured behavioral interventions and comprehensive clinical management remain the cornerstone of care. Although these drugs may not directly treat FTD, they offer hope for future advancements and potential treatments across a broader spectrum of dementia and can assist the medical strategies that your Isaac Health team implements as part of your care plan.
The Power of Resilience and Adaptation
Amidst the challenges a patient and families face on a day-to-day basis there’s something to be said for resilience and adaptation. Individuals with FTD, like Dr. Stern and Isaac Health patients, actively manage their condition by implementing lifestyle changes, engaging in cognitive exercises, and fostering social connections. Dr. Stern’s journey of accepting his diagnosis, proposing to his partner, and planning for the future highlights the strength and determination of those facing dementia. These stories underscore the importance of support, awareness, and research to improve the diagnosis and management of FTD.
Finding Care and Support
Early detection and diagnosis of frontotemporal dementia can be life-altering for individuals and their families–which allows for proactive planning, access to appropriate care, and the potential for participating in future treatments. Thank you to WSJ for ‘being on our team’ and shedding light on the transformative power of early intervention. Navigating personality, language, or cognitive changes in a loved one can feel overwhelming, but early answers provide clarity and protection.
Connecting with a Cognitive Specialist
Navigating personality, language, or cognitive changes in a loved one can feel overwhelming, but early answers provide clarity and protection. If you are noticing persistent shifts in behavior or communication, schedule an evaluation with our clinical team to consult with a board-certified cognitive neurologist. If you are already an active Isaac Health patient, you can reach out directly to your provider through the patient portal to discuss personalized symptom management.
